Abstract
It is now well accepted that colon cancer evolves from a multi-step process and is a disease strongly influenced by environmental factors, with diet being one of the most important modifying agents. Among dietary factors, there is cogent evidence indicating a protective effect of fish oil feeding with respect to colonic tumor development. We have recently demonstrated that the balance between colonic epithelial cell proliferation and programmed cell death (apoptosis) can be favorably modulated by feeding fish oil, containing n-3 polyunsaturated fatty acids, specifically, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). We propose that the suppression of colonic tumor development by dietary n-3 polyunsaturated fatty acids may be due to an effect on the subcellular localization of oncogenic p21 ras. The potential for fish oil feeding to antagonize ras-dependent signal transduction is significant because the acquisition of chronically activated ras via mutation or overexpression is a relatively early step in colorectal cancer development.
Current Organic Chemistry
Title: Dietary Fish Oil Reduces Colon Cancer Risk
Volume: 4 Issue: 11
Author(s): Esther D. Collett, Laurie A. Davidson, Joanne R. Lupton and Robert S. Chapkin
Affiliation:
Abstract: It is now well accepted that colon cancer evolves from a multi-step process and is a disease strongly influenced by environmental factors, with diet being one of the most important modifying agents. Among dietary factors, there is cogent evidence indicating a protective effect of fish oil feeding with respect to colonic tumor development. We have recently demonstrated that the balance between colonic epithelial cell proliferation and programmed cell death (apoptosis) can be favorably modulated by feeding fish oil, containing n-3 polyunsaturated fatty acids, specifically, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). We propose that the suppression of colonic tumor development by dietary n-3 polyunsaturated fatty acids may be due to an effect on the subcellular localization of oncogenic p21 ras. The potential for fish oil feeding to antagonize ras-dependent signal transduction is significant because the acquisition of chronically activated ras via mutation or overexpression is a relatively early step in colorectal cancer development.
Export Options
About this article
Cite this article as:
Collett D. Esther, Davidson A. Laurie, Lupton R. Joanne and Chapkin S. Robert, Dietary Fish Oil Reduces Colon Cancer Risk, Current Organic Chemistry 2000; 4 (11) . https://dx.doi.org/10.2174/1385272003375824
DOI https://dx.doi.org/10.2174/1385272003375824 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Screening Novel SAHA Derivatives as Anti-lung Carcinoma Agents: Synthesis, Biological Evaluation, Docking Studies and Further Mechanism Research between Apoptosis and Autophagyetween Apoptosis and Autophagy
Anti-Cancer Agents in Medicinal Chemistry Cancer Resistance to Type II Topoisomerase Inhibitors
Current Medicinal Chemistry PEGylated Peptide-Based Imaging Agents for Targeted Molecular Imaging
Current Protein & Peptide Science H3K4 Methylation Status and Lysine Specific Methyltransferase KMT2C Expression Correlate with Prognosis in Lung Adenocarcinoma
Current Molecular Pharmacology Quercetin in Cancer Treatment, Alone or in Combination with Conventional Therapeutics?
Current Medicinal Chemistry Role of Drug Metabolism in the Cytotoxicity and Clinical Efficacy of Anthracyclines
Current Drug Metabolism The Therapeutic Impact of Manipulating Microbiota in Inflammatory Bowel Disease
Current Pharmaceutical Design Role of Chemokines and Their Receptors in Cancer
Current Pharmaceutical Design The Association Between the Chronic Use of Non-Steroidal Anti- Inflammatory Drugs and Oxidative and Inflammatory Markers in the Elderly
Inflammation & Allergy - Drug Targets (Discontinued) New Improved Drug Delivery Technologies for Pentacyclic Triterpenes: A Review
Protein & Peptide Letters <i>In Silico</i> Investigation: Opening Doors to Novel Thymidylate Synthase Inhibitors
Current Enzyme Inhibition Cardiotoxicity of Molecularly Targeted Agents
Current Cardiology Reviews Phase 1 Clinical Experience Using Intravenous Administration of PV701, an Oncolytic Newcastle Disease Virus
Current Cancer Drug Targets “Letting the Air In” Can Set the Stage for Tumor Recurrences
Current Cancer Therapy Reviews Recent Developments on 1,2,4-Triazole Nucleus in Anticancer Compounds: A Review
Anti-Cancer Agents in Medicinal Chemistry Diffusion-Weighted Magnetic Resonance Imaging in Pelvic Cancer
Current Medical Imaging Novel Polymethoxylated Chalcones as Potential Compounds Against KRAS-Mutant Colorectal Cancers
Current Pharmaceutical Design Targeting Epidermal Growth Factor Receptor in Solid Tumors: Critical Evaluation of the Biological Importance of Therapeutic Monoclonal Antibodies
Current Medicinal Chemistry New Trends in Liposome-based Drug Delivery in Colorectal Cancer
Mini-Reviews in Medicinal Chemistry Amino Thiols, Detoxification and Oxidative Stress in Pre-Eclampsia and Other Disorders of Pregnancy
Current Pharmaceutical Design